The Key Drivers behind Novo Nordisk’s Growth in the Diabetes Market in China
To enter the Chinese Pharmaceutical market, “Big Pharma” has adopted different strategies to tackle the challenges specific to the country in terms of size, demographics, specific sales channels and logistics adjustments. While the majority of Global Pharmaceutical players have opted for an aggressi...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Academy of Economic Studies (ASE)
2013-12-01
|
| Series: | European Journal of Interdisciplinary Studies |
| Subjects: | |
| Online Access: | http://www.ejist.ro/files/pdf/376.pdf |